Caitong International Asset Management Co., LTD Ultragenyx Pharmaceutical Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 899 shares of RARE stock, worth $39,214. This represents 0.04% of its overall portfolio holdings.
Number of Shares
899
Previous 899
-0.0%
Holding current value
$39,214
Previous $37.8 Million
-0.0%
% of portfolio
0.04%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
343Shares Held
86.6MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$438 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$244 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$187 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$119 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$110 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.06B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...